Member Societies

• All
• Nov. 16 (Thu)
• Nov. 17 (Fri)
• Nov. 18 (Sat)

• KSG
• KSGE
• KASL
• KSNM
• KPBA
• KCHUGR
• KASID
• KSGC
• KSPGHAN
• Gut and Liver
• Insurance Policy

Symposium 22 : Emerging issue on nonalcoholic fatty liver disease (NAFLD) English

Date / Time	Nov. 17 (Fri), 09:00-10:20
Room	Vista 2
Chair(s)	Sanghoon Park (Hallym University, Korea) Jin-Woo Lee (Inha University, Korea)
Speakers	09:00-09:20	Metabolic drugs in patients with NAFLD and diabetes: pioglitazone, GLP-1 agonist, and SGLT2 inhibitor Soon Sun Kim (Ajou University, Korea)
	09:20-09:40	Metabolic and genetic risk factors for NAFLD George Boon-Bee Goh (Singapore General Hospital, Singapore)
	09:40-10:00	Inter-organ crosstalk in the pathogenesis of NAFLD Dae Won Jun (Hanyang University, Korea)
	10:00-10:20	Risk factors and prognosis of NAFLD-related hepatocellular carcinoma Sang Bong Ahn (Eulji University, Korea)

Symposium 26 : Recent updates of cellular mechanisms and antifibrotic therapy in liver fibrosis Korean

Date / Time	Nov. 17 (Fri), 10:40-12:00
Room	Vista 2
Chair(s)	Won Young Tak (Kyungpook National University, Korea) Neung Hwa Park (University of Ulsan, Korea)
Speakers	10:40-11:00	Mechanisms of fibrosis progression: factors activating intrahepatic macrophages Hyuk Soo Eun (Chungnam National University, Korea)
	11:00-11:20	Crosstalk between stellate cells and immune cells in liver fibrosis Young-Sun Lee (Korea University, Korea)
	11:20-11:40	Roles of sinusoidal endothelial cells in liver fibrosis and portal hypertension Moon Young Kim (Yonsei University Wonju, Korea)
	11:40-12:00	Therapeutic advances in anti-fibrosis therapy in chronic liver diseases Seung Kak Shin (Gachon University, Korea)

Symposium 29 : Key questions on the management of hepatocellular carcinoma English

Date / Time	Nov. 17 (Fri), 13:30-14:50
Room	Vista 2
Chair(s)	Hyunchul Rhim (Sungkyunkwan University, Korea) Jongyoung Choi (The Catholic University of Korea, Korea)
Speakers	13:30-13:50	HCC surveillance for non-cirrhotic patients: the target population and surveillance tool Do Young Kim (Yonsei University, Korea)
	13:50-14:10	Selection of curative options for oligometastasis from HCC Wonseok Kang (Sungkyunkwan University, Korea)
	14:10-14:30	Early switch to or frontline systemic therapy for intermediate stage HCC Yuri Cho (National Cancer Center, Korea)
	14:30-14:50	Biomarker-based precision care of systemic therapy in HCC Stephen Chan (The Chinese University of Hong Kong, Hong Kong)

Symposium 32 : Controversial issue on liver disease Korean

Date / Time	Nov. 17 (Fri), 15:10-16:30
Room	Vista 2
Chair(s)	Joo Hyun Sohn (Hanyang University, Korea) Jong Eun Yeon (Korea University, Korea)
Speakers	15:10-15:30	Benign liver tumors: which to perform surgical resection and follow-up care? Jeong-Ju Yoo (Soonchunhyang University, Korea)
	15:30-15:50	When to test for hepatitis D virus and how to treat it? Young Eun Chon (CHA University, Korea)
	15:50-16:10	Ongoing issues in chronic hepatitis C: use of DAAs in HCC, reinfection, and surveillance after SVR Young Youn Cho (Chung-Ang University, Korea)
	16:10-16:30	Prevention and management of gastrointestinal bleeding during atezolizumab-bevacizumab for HCC Hee Yeon Kim (The Catholic University of Korea, Korea)